Key Findings
The Europe irritable bowel syndrome treatment market is evaluated to project a CAGR of 7.16% during the forecast period, 2021-2028. The growing patient awareness toward irritable bowel syndrome (IBS) treatment is the key driver of market growth in the region.

Market Insights
The United Kingdom, France, Germany, Poland, Belgium, Russia, Italy, and Rest of Europe are evaluated for the Europe irritable bowel syndrome treatment market growth analysis. In Germany, the global companies have a strong base, developing products, given the growing prevalence of several chronic diseases and the increasing aging population. According to the Germany Federal Statistical Office 2020 report, the geriatric population is estimated to reach 21.4 million by 2040. As per a 2017 study, around 1.34% of the population was diagnosed with IBS.
In France, the IBS prevalence stands at 10%, according to a 2019 article. Several subtypes of IBS have been assessed on the basis of predominant stool pattern. These include IBS with mixed bowel patterns of both constipation and diarrhea (IBS-M), IBS with diarrhea (IBS-D), and IBS with constipation (IBS-C). Further, according to the World Population Ageing 2019 report, the aging population is set to reach 16.09 million by 2030. Such factors are expected to drive market growth in France. In Belgium, around 38% of the adult population has one or more gastrointestinal disorders, according to a 2020 article. The prevalence of chronic constipation is 11%, and that of chronic stomach problems (dyspepsia) is 5%. This has resulted in increased doctor consultations and a decreased quality of life. Such developments are projected to increase the market growth in Belgium.

Competitive Insights
Some of the distinguished players of the market are Lannett Company Inc, Allergan Plc, Novartis AG, AstraZeneca Plc, GlaxoSmithKline Plc, etc.
Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments